Evotec Buys Cell-based Reagents Firm for up to $2.9M | GenomeWeb

NEW YORK (GenomeWeb News) – Evotec today announced it has acquired custom cell and cell-based reagents firm Cell Culture Service for up to €2.2 million ($2.9 million).

Evotec will pay €1.15 million in cash as part of the deal. CCS is also eligible for an earn-out payment of €1.05 million due one year after the acquisition and dependent on certain revenue targets being met.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.